The growth of Real-World Evidence (RWE) from sources including patient registries, claims data, electronic medical records, digital health technologies and more has powered the ability of Medical Affairs to drive patient outcomes. Here, the MAPS Executive Consortium describes how.
MAPS is pleased to share our 2023 Medical Metrics Benchmarking Report, based on findings from 51 leading organizations representing the Pharmaceutical, Biotech, and Medical and Diagnostic Device sectors.
In today’s rapidly evolving pharmaceutical environment, Medical Affairs teams are under increasing pressure to understand how to go beyond “activity engagement” metrics and identify areas of opportunity to advance evidenced-based medicine and treatment with current available data.
This webinar will provide a historical perspective on value, as well as insights to help Medical Affairs professionals measure and demonstrate the impact of their activities in a complex environment.
As Medical Affairs teams strive to identify areas of opportunity and demonstrate their value, understanding the importance of data-driven strategies is essential. In this webinar, we will discuss the historical perspective on value in Medical Affairs, as well as strategies to measure and demonstrate impact in an evolving pharmaceutical environment. Join us to learn more about how data-driven strategies can help you gain a better understanding of your Medical Affairs activities and provide insights into areas of opportunity.
AI Application in Medical Affairs – Advanced Course
This course includes
What you will learn?
Course description
This comprehensive course is tailored to professionals in the pharmaceutical, biotechnology, and medical device industries who work in Medical Affairs functions. It addresses the impact of technology and automation on Medical Affairs in the post–COVID-19 era, which has been accelerated by the pandemic.
This curriculum delves into the utilization of AI in the creation of personalized content, management of medical queries, and prediction of customer engagement pathways.
Additionally, it examines the use of AI in MLR review processes to allow for a more strategic allocation of resources and highlights current AI applications utilized in MLR reviews.
Furthermore, this curriculum explores the application of AI in personalizing customer interactions and utilizing next-best actions, content affinity, and channel affinity in Medical Affairs interactions, as well as AI’s role in generating insights.
Our on-demand content, which includes animations and rich graphics, is presented in a clear and concise manner, making it easy to understand and apply in real-world scenarios. Upon successful completion of the Certification Quiz, a downloadable version of this curriculum will be made available to users..
Learning activities/assessments: eLearning self-paced modules, knowledge checks, and a brief pre- and post-test
Approximate time to complete the activity: 120 minutes
Prerequisites: The eLearning module “Artificial Intelligence Foundations for Medical Affairs” is highly recommended.
Audience: Intermediate-level content for Medical Affairs professionals who have digital experience
Credits: As an IACET Accredited Provider, Medical Affairs Professional Society offers IACET CEUs for its learning events that comply with the ANSI/IACET Continuing Education and Training Standard. MAPS is authorized by IACET to offer 0.2 CEUs for this program.
Participants/attendees must complete 100% of the program and receive a minimum of 70% on the post program assessment.
At the conclusion of this online learning activity, participants should be able to:
1. Recall the impact of technology and automation across Medical Affairs in a post-Covid-19 world especially accelerated due to the pandemic
2. Articulate the potential business cases for AI within the Medical Affairs function
3. Describe the use of AI in modular content creation to deliver personalized targeted content
4. Explain how AI can help in the content supply chain and query management
5. Identify how the integration of AI and data sources predicts an ideal customer engagement pathway
6. Explain the need for AI in MLR review to allow reviewers to do more strategic work
7. List a few examples of AI applications in MLR review
8. Explain the role of AI in advanced MI portal search
9. Discuss the importance of conversational AI in customer interactions
10. Describe how AI can help in insight generation
11. List a few use cases of insight generation using AI in Medical Affairs
In this interview recorded at the MAPS 2023 Annual Meeting in Nashville, MAPS speaks with Bill Tidwell, Director, Field Based Medicine | Health System and Payor Strategy at Boehringer Ingelheim about engaging organized customers.
As evidence generation becomes more advanced and integrated into Medical Affairs strategic plans, there is a greater need to maximize its impact by leveraging emerging digital technologies to communicate complex clinical and nonclinical data.
In this episode, listeners will better understand what innovative content is in the context of Medical Information while setting expectations of HCPs in accessing innovative content.
Advisory boards bring together a selection of key opinion leaders to discuss a topic important to a life sciences company. Here is how to use engagement technologies to generate actionable insights from your next ad board.
All industries are rushing to harness rich data in order to drive progress, but how can the many data sources help Medical Affairs to show impact and drive improved patient outcomes?
In part three of this four-part series, we will discuss:
This Webinar series explores the fundamental concept of big data in Medical Affairs, from which sources can we retrieve this, what are the broader considerations when utilizing data in health and what impact this can have on our organizations, physicians, and patients, now and in the future. These presentations will feature real-world cases that are relevant to regional and country Medical Affairs leaders, in order to highlight long-term aspirational and short-term tangible projects.
In this interview recorded at the MAPS 2023 Annual Meeting in Nashville, MAPS speaks with Robin Winter-Sperry and Robert Kersting, PharmD, Global Head, Scientific Alliances, Novartis, about the need for multi-stakeholder partnerships.